Legalising lower dosage cannabis products could 'ignite industry'

Legalising lower dosage cannabis products could 'ignite industry'
Mitch Cuevas, pharmaceutical director at Katikati based medicinal cannabis firm Eqalis, said NZ is 'missing out' on an obvious export opportunity. (Image: Eqalis)
Brent Melville
Easing restrictions on low-level cannabidiol (CBD) for over-the-counter sales could boost cannabis earnings fourfold, creating a $2 billion sector within the next eight years, a new report says.Dr Nick Marsh, an analyst and consultant with Next Corp, said regulatory reform allowing expanded use of low potency CBD for nutraceuticals and food products could ignite the industry’s earning power.In New Zealand, any strength CBD is scheduled as a restricted medicine under the Medicines Act and therefore must be prescribed by a medical professio...

More Health

Meet Dr Grok. Finally, a physician who's available and who gets me
Health

Meet Dr Grok. Finally, a physician who's available and who gets me

Human doctors rarely have time to talk for long, or dig deep. Chatbots are different.

Health NZ AI trial boosts ED productivity
Health

Health NZ AI trial boosts ED productivity

AI scribes are being rolled out in more than 16 EDs nationwide.

John Anthony 28 Oct 2025
Protein isn’t everything. Here’s what to know
The Life

Protein isn’t everything. Here’s what to know

Lots of folks are trying to amp up protein’s hero status.

How Pharmac's set-up risks higher health costs
Economy

How Pharmac's set-up risks higher health costs

Pharmac's fixed budget discourages use of cost-saving medicines common elsewhere.

Pattrick Smellie 23 Oct 2025